Press Releases
Stay up to date with press releases covering announcements, company news, product launches, and business updates.
Publish your press release
Pharma Companies Turn to Strategic CDMO Partnerships as Development Needs Evolve
EIN Presswire
SAN DIEGO, CA, UNITED STATES, September 10, 2026 /EINPresswire.com/ -- Pharmaceutical companies are rethinking how they choose development and manufacturing partners.
SEALSQ Expands its Quantum Highway™: Nine Interconnected Hubs Now Link La Línea, Murcia, Toulouse, Meyreuil, Grenoble, Geneva, Lausanne and the Future Swiss-based Center, and Extend the Sovereign Quantum Corridor to Chicago with EeroQ
GlobeNewswire, Inc.
Geneva, Switzerland, Sept. 09, 2026 (GLOBE NEWSWIRE) -- The Quantum Highway physically connects every layer of the SEALQUANTUM.com Sovereign Quantum Vertical Stack, from post-quantum device manufacturing in Spain, through secure-element and ASIC...
SOTIO Doses First Patient in Phase 1/2 CADENCIA-01 Clinical Trial of SOT109, a CDH17-Targeting ADC for Colorectal Cancer
GlobeNewswire, Inc.
SOT109 targets CDH17, a highly prevalent GI cancer antigen expressed in more than 90% of colorectal cancers, combining a clinically validated payload with an optimized ADC design intended to maximize therapeutic potential SOT109 is the only...
ONWARD Medical Reports First Half 2026 Results with Strong Product Revenue Growth and Continued Progress across ARC Therapy Pipeline
GlobeNewswire, Inc.
THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR:...
Coin Cell Batteries Market to Reach USD 3.27 Billion by 2035, Driven by Wearables and Medical Devices
EIN Presswire
Asia-Pacific is the fastest-growing region, reflecting a surge in wearable technology and IoT applications.
MetaShape Pharma to Showcase New Data and Strategic Updates at MedInvest and RESI Life Sciences Investor Conferences
EIN Presswire
Company to present new data supporting MS001 as a differentiated GLP-1 co-therapy addressing energy expenditure—the other side of the energy-balance equation RIEHEN, SWITZERLAND, September 8, 2026 /EINPresswire.com/ -- MetaShape Pharma AG...
CRISPR Therapeutics to Present at the Morgan Stanley 24th Annual Global Healthcare Conference
GlobeNewswire, Inc.
ZUG, Switzerland and BOSTON, Sept. 08, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday,...
Roivant Announces Positive Results from PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) and Unveils Ongoing Phase 3 PHrontier Study
GlobeNewswire, Inc.
PHocus met its primary endpoint, demonstrating a clinically meaningful and statistically significant placebo-adjusted reduction in pulmonary vascular resistance (PVR) of -56.3% (p<0.0001) at Week 16, the highest ever reported PVR reduction in any...
Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
GlobeNewswire, Inc.
U.S. Food and Drug Administration accepted the New Drug Application with Priority Review for tinlarebant for the treatment of Stargardt disease type 1; Prescription Drug User Fee Act target action date of February 12, 2027 If approved, tinlarebant...
Ascom secures major framework agreement and two subsequent project awards, strengthening its long-term presence in Norway’s healthcare market
GlobeNewswire, Inc.
Baar, Switzerland, 8 September 2026 Ascom has secured one of two major framework agreements with Helse Sør-Øst (HSØ), Norway’s largest regional health authority.
Nina Capital Launches Clinical Advisory Board with Internationally Recognized Physicians
EIN Presswire
Four internationally recognized physician leaders in interventional neurology, medical imaging, and drug development join the firm's inaugural Clinical Advisor.
8th Swiss Parabolic Flight Campaign: A Clear Shift Toward Commercial Space
EIN Presswire
ZURICH, ZURICH, SWITZERLAND, September 7, 2026 /EINPresswire.com/ -- The 8th Swiss Parabolic Flight Campaign, organized by the Center for Space and Aviation Switzerland and Liechtenstein (CSA), take place from 7 to 11 September 2026 at the...
UNITAR and Empower School of Health Deliver Inaugural Youth Career Accelerator in Health
UN International Training and Research Center
07 September 2026, Geneva, Switzerland - UNITAR, in partnership with Empower School of Health, delivered the inaugural edition of the Youth Career Accelerator in Health (YCAH), bringing students and early-career professionals from 16 countries to...
Roivant to Present Topline Results from the Phase 2 PHocus Study of Mosliciguat in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) at the ERS Congress 2026 on Tuesday, September 8, 2026, and Host Investor Call
GlobeNewswire, Inc.
BASEL, Switzerland and LONDON and NEW YORK, Sept. 06, 2026 (GLOBE NEWSWIRE) -- Roivant (Nasdaq: ROIV) and Pulmovant today announced that results from the Phase 2 PHocus study of mosliciguat in patients with pulmonary hypertension associated with...
ONWARD Medical to Announce First-Half 2026 Results on September 9, 2026
GlobeNewswire, Inc.
EINDHOVEN, the Netherlands, Sept. 04, 2026 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal...
Pharvaris Presents Translational, Nonclinical, and Clinical Data at Bradykinin Symposium 2026
GlobeNewswire, Inc.
ZUG, Switzerland, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated...
Newron Pharmaceuticals to Participate in H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire, Inc.
MILAN, Italy and MORRISTOWN, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the...
Nxera Pharma to Receive $8.6 Million Milestone Payment from Centessa Pharmaceuticals Following Late-stage Development Progress
GlobeNewswire, Inc.
Tokyo, Japan and Cambridge, UK, 3 September 2026 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) today announces that Centessa Pharmaceuticals Limited (“Centessa”), a wholly-owned subsidiary of Eli Lilly and Company (“Lilly”), has...
ONWARD Medical Announces First Implant in New Clinical Feasibility Study Evaluating ARC-IM System to Restore Mobility After Spinal Cord Injury
GlobeNewswire, Inc.
The EIGER study will assess the safety and preliminary effectiveness of the investigational ARC-IM® System to restore mobility after both subacute and chronic spinal cord injury ARC-IM is an implanted neuromodulation platform designed to deliver...
Swiss Privacy Goes East: MoltenRock Ships Native Chinese Version as Bern and Beijing Deepen Ties
EIN Presswire
A fully local, Secure Enclave security app for AI agents is now native in Simplified Chinese: no cloud, no account, nothing leaves the user's Mac. ZüRICH, SWITZERLAND, August 28, 2026 /EINPresswire.com/ -- This week, the headlines about...
Sign up for:
Switzerland Health Monitor
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.